Skip to main content
Clinical Trials/NCT04662320
NCT04662320
Active, not recruiting
Not Applicable

Promoting Healing of Nerves Through Electrical Stimulation

Checkpoint Surgical Inc.5 sites in 1 country100 target enrollmentSeptember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cubital Tunnel Syndrome
Sponsor
Checkpoint Surgical Inc.
Enrollment
100
Locations
5
Primary Endpoint
Change in Grip Strength at 1 year.
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

This study is evaluating a new therapeutic use of electrical stimulation to promote nerve healing and improve functional recovery following surgical intervention for nerve compression. A single dose of the therapeutic stimulation is delivered as part of the surgical intervention to address compression of the ulnar nerve at the elbow.

Detailed Description

Preliminary research has shown that delivering a brief period of electrical stimulation following nerve repair promotes nerve healing and functional recovery. This study is investigating the use of a single dose of therapeutic electrical stimulation to promote nerve healing. The therapy is delivered as part of the surgical intervention to address compression of the ulnar nerve at the elbow, commonly referred to as Cubital Tunnel Syndrome.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
December 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Checkpoint Surgical Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Electrodiagnostic evidence of ulnar neuropathy at the elbow.
  • Are candidates for surgical intervention.
  • Evidence of motor involvement such as intrinsic muscle atrophy or weakness.
  • Are age 18-80 years.
  • Signed and dated informed consent form.

Exclusion Criteria

  • Severe comorbid condition, such as arrythmia or congestive heart failure, preventing surgery
  • Previous history or current transection of ulnar nerve, or concomitant upper extremity nerve injury
  • Global peripheral neuropathy affecting the hands
  • Age less than 18 or greater than 80 years
  • Un-affected hand maximum grip strength \<12kg

Outcomes

Primary Outcomes

Change in Grip Strength at 1 year.

Time Frame: 1 year

Change in grip strength at 1 year from baseline (pre-operative) assessment.

Secondary Outcomes

  • Medical Research Council (MRC) motor grading.(Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Patient Reported Outcome Measurement System (PROMIS) Upper Extremity Function(Pre-surgery, 10 days, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Michigan Hand Questionnaire (MHQ)(Pre-surgery, 10 days, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • 2-point discrimination(Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Lateral Pinch Strength(Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Patient Reported Outcome Measurement System (PROMIS) Pain Interference(Pre-surgery, 10 days, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Electromyography (EMG)(Pre-surgery, 3 months, and 7 months)
  • Grip Strength(Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Semmes-Weinstein Monofilament Testing(Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Maximal finger spread measurement.(Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 year)
  • Nerve Conduction Velocity (NCV)(Pre-surgery, 3 months, and 7 months)

Study Sites (5)

Loading locations...

Similar Trials